These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11897053)

  • 1. Microplate screening of the differential effects of test agents on Hoechst 33342, rhodamine 123, and rhodamine 6G accumulation in breast cancer cells that overexpress P-glycoprotein.
    Sarver JG; Klis WA; Byers JP; Erhardt PW
    J Biomol Screen; 2002 Feb; 7(1):29-34. PubMed ID: 11897053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of ATP-dependent multidrug transport by P-glycoprotein.
    Shapiro AB; Ling V
    Acta Physiol Scand Suppl; 1998 Aug; 643():227-34. PubMed ID: 9789565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
    Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE
    Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.
    Kang DI; Kang HK; Gwak HS; Han HK; Lim SJ
    Drug Deliv; 2009 Jul; 16(5):261-7. PubMed ID: 19538007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells.
    Kitazaki T; Oka M; Nakamura Y; Tsurutani J; Doi S; Yasunaga M; Takemura M; Yabuuchi H; Soda H; Kohno S
    Lung Cancer; 2005 Sep; 49(3):337-43. PubMed ID: 15955594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of human leukemia cells with multidrug-resistance phenotype using multilabeling with fluorescent dyes.
    Lautier D; Lahmy S; Canitrot Y; Vigo J; Viallet P; Salmon JM
    Anticancer Res; 1993; 13(5A):1557-63. PubMed ID: 8239535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
    Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG
    Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
    Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM
    Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry evaluation of the multidrug-resistant phenotype with functional tests involving uptake of daunorubicin, Hoechst 33342, or rhodamine 123: a comparative study.
    Lizard G; Roignot P; Maynadie M; Lizard-Nacol S; Poupon MF; Bordes M
    Cancer Detect Prev; 1995; 19(6):527-34. PubMed ID: 8925522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2'[(18)F]-fluoroethylrhodamine B is a promising radiotracer to measure P-glycoprotein function.
    Trencsényi G; Kertész I; Krasznai ZT; Máté G; Szalóki G; Szabó Judit P; Kárpáti L; Krasznai Z; Márián T; Goda K
    Eur J Pharm Sci; 2015 Jul; 74():27-35. PubMed ID: 25857708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance phenotype evaluation by immunofluorescence and functional tests: comparison of two monoclonal antibodies and three fluorescent dyes in three cells lines.
    Maynadie M; Lizard G; Solary E; Roignot P; Carli PM
    Anticancer Res; 1994; 14(6B):2605-9. PubMed ID: 7872688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of rhodamines efflux mediated by the multidrug resistance protein (MRP1).
    Saengkhae C; Loetchutinat C; Garnier-Suillerot A
    Biophys J; 2003 Sep; 85(3):2006-14. PubMed ID: 12944313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein.
    Wei N; Sun H; Wang F; Liu G
    Cancer Chemother Pharmacol; 2011 May; 67(5):1017-25. PubMed ID: 20640574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
    Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE
    Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein.
    Wang E; Casciano CN; Clement RP; Johnson WW
    Cancer Res; 2001 Oct; 61(20):7525-9. PubMed ID: 11606389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
    Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of the chemical charge of rhodamine dyes to multiple drug resistance.
    Lampidis TJ; Castello C; del Giglio A; Pressman BC; Viallet P; Trevorrow KW; Valet GK; Tapiero H; Savaraj N
    Biochem Pharmacol; 1989 Dec; 38(23):4267-71. PubMed ID: 2597199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.
    Tang F; Ouyang H; Yang JZ; Borchardt RT
    J Pharm Sci; 2004 May; 93(5):1185-94. PubMed ID: 15067695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells.
    Lautier D; Canitrot Y; Salmon JM
    Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.